DarioHealth Corp. (DRIO): Price and Financial Metrics

DarioHealth Corp. (DRIO): $6.14

0.61 (+11.03%)

POWR Rating

Component Grades














  • Value is the dimension where DRIO ranks best; there it ranks ahead of 45.07% of US stocks.
  • DRIO's strongest trending metric is Stability; it's been moving up over the last 179 days.
  • DRIO ranks lowest in Quality; there it ranks in the 3rd percentile.

DRIO Stock Summary

  • The ratio of debt to operating expenses for DarioHealth Corp is higher than it is for about merely 5.15% of US stocks.
  • With a year-over-year growth in debt of -46.05%, DarioHealth Corp's debt growth rate surpasses only 8.55% of about US stocks.
  • As for revenue growth, note that DRIO's revenue has grown 170.76% over the past 12 months; that beats the revenue growth of 95.2% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to DarioHealth Corp, a group of peers worth examining would be UCL, BSGM, COUP, VCEL, and PLUG.
  • DRIO's SEC filings can be seen here. And to visit DarioHealth Corp's official web site, go to mydario.com.

DRIO Valuation Summary

  • DRIO's EV/EBIT ratio is -3.3; this is 111.26% lower than that of the median Healthcare stock.
  • Over the past 101 months, DRIO's price/earnings ratio has gone up 1.
  • DRIO's price/sales ratio has moved NA NA over the prior 101 months.

Below are key valuation metrics over time for DRIO.

Stock Date P/S P/B P/E EV/EBIT
DRIO 2021-08-31 17.2 1.9 -4.4 -3.3
DRIO 2021-08-30 15.8 1.7 -4.0 -2.9
DRIO 2021-08-27 16.4 1.8 -4.2 -3.1
DRIO 2021-08-26 15.7 1.7 -4.0 -2.9
DRIO 2021-08-25 15.5 1.7 -4.0 -2.9
DRIO 2021-08-24 15.7 1.7 -4.0 -2.9

DRIO Growth Metrics

    Its year over year cash and equivalents growth rate is now at 412.9%.
  • The 4 year net cashflow from operations growth rate now stands at -137.47%.
  • Its 5 year revenue growth rate is now at 427.49%.
DRIO's revenue has moved up $13,219,000 over the prior 15 months.

The table below shows DRIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 20.513 -50.409 -78.766
2021-09-30 16.565 -42.033 -66.359
2021-06-30 12.978 -33.39 -50.907
2021-03-31 9.504 -23.723 -37.446
2020-12-31 7.576 -17.736 -33.103
2020-09-30 7.294 -13.828 -30.767

DRIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DRIO has a Quality Grade of F, ranking ahead of 2.68% of graded US stocks.
  • DRIO's asset turnover comes in at 0.156 -- ranking 147th of 186 Medical Equipment stocks.
  • SPNE, ATRI, and ICAD are the stocks whose asset turnover ratios are most correlated with DRIO.

The table below shows DRIO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.156 0.284 28.266
2021-03-31 0.174 0.296 38.633
2020-12-31 0.266 0.332 847.338
2020-09-30 0.283 0.384 132.027
2020-06-30 0.404 0.439 -93.685
2020-03-31 0.426 0.403 -274.333

DRIO Price Target

For more insight on analysts targets of DRIO, see our DRIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $27.53 Average Broker Recommendation 1.5 (Moderate Buy)

DRIO Stock Price Chart Interactive Chart >

Price chart for DRIO

DRIO Price/Volume Stats

Current price $6.14 52-week high $21.68
Prev. close $5.53 52-week low $4.11
Day low $5.28 Volume 421,000
Day high $6.29 Avg. volume 236,665
50-day MA $5.88 Dividend yield N/A
200-day MA $10.06 Market Cap 135.00M

DarioHealth Corp. (DRIO) Company Bio

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Blood Glucose Monitoring System, a pocket-sized, blood glucose monitoring device. It offers DarioEngage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications; and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy, hospitals, and distributors; and through online. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.

DRIO Latest News Stream

Event/Time News Detail
Loading, please wait...

DRIO Latest Social Stream

Loading social stream, please wait...

View Full DRIO Social Stream

Latest DRIO News From Around the Web

Below are the latest news stories about DarioHealth Corp that investors may wish to consider to help them evaluate DRIO as an investment opportunity.

LifeSci Capital Thinks DarioHealth’s Stock is Going to Recover

In a report released yesterday, Rakhit Rahul from LifeSci Capital maintained a Buy rating on DarioHealth (DRIO – Research Report), with a price target of $31.00. The company's shares closed last Tuesday at $8.80, close to its 52-week low of $7.56. According to TipRanks.com, Rahul has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -29.5% and a 0.0% success rate. Rahul covers the Healthcare sector, focusing on stocks such as Mountain Crest Acquisition II, Nano-X Imaging, and Lucira Health. Currently, the analyst consensus on DarioHealth is a Moderate Buy with an average price target of $22.50, a 164.1% upside from current levels.

Catie Powers on TipRanks | February 9, 2022

DarioHealth Publishes Clinical Outcomes Demonstrating the Impact of Using a Single Digital Therapeutics Platform for Multiple Conditions

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced the publication of a retrospective, real-world study demonstrating the impact of managing blood pressure and diabetes together on the same digital platform in the leading peer-reviewed journal for digital medicine and health, the Journal of Medical Internet Research.

Yahoo | February 9, 2022

DarioHealth Announces Four New Employer Contracts

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced several new contracts to deliver its digital therapeutics solutions for four new employers. The new accounts are expected to launch during the first and second quarters of 2022.

Yahoo | February 8, 2022

DRIO: 2022 Outlook, Physimax Acquisition

By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Since Our Last Update Since our last update , DarioHealth Corp. (NASDAQ:DRIO) had issued a number of press releases. Five employer contracts, a contract with a provider, a benefits brokerage, and a large regional health plan were signed since mid-November. Dario hosted an Investor Webinar on January 19, 2022 highlighting

Yahoo | January 24, 2022

What You Need To Know About DarioHealth Corp.'s (NASDAQ:DRIO) Investor Composition

The big shareholder groups in DarioHealth Corp. ( NASDAQ:DRIO ) have power over the company. Large companies usually...

Yahoo | January 22, 2022

Read More 'DRIO' Stories Here

DRIO Price Returns

1-mo -2.23%
3-mo 1.82%
6-mo -52.66%
1-year -70.58%
3-year -39.82%
5-year -85.92%
YTD -52.66%
2021 -9.24%
2020 117.84%
2019 -57.95%
2018 -51.25%
2017 -50.77%

Continue Researching DRIO

Want to see what other sources are saying about DarioHealth Corp's financials and stock price? Try the links below:

DarioHealth Corp (DRIO) Stock Price | Nasdaq
DarioHealth Corp (DRIO) Stock Quote, History and News - Yahoo Finance
DarioHealth Corp (DRIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.5223 seconds.